Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 14 (5) , 259-269
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertensionAmerican Heart Journal, 2000
- Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertensionKidney International, 2000
- Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Modulates the Human In Vivo Metabolism of BradykininCirculation, 2000
- Angiotensin-converting enzyme (ACE) gene polymorphisms, serum ACE activity and blood pressure in a Spanish-Mediterranean populationJournal of Human Hypertension, 2000
- Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled studyEuropean Heart Journal, 1999
- Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1Hypertension, 1998
- ACE Insertion/Deletion Genotype Affects Bradykinin MetabolismJournal of Cardiovascular Pharmacology, 1998
- ACE Gene Polymorphism: Ischemic Heart Disease and Longevity in 10 150 IndividualsCirculation, 1997
- A Prospective Evaluation of an Angiotensin-Converting–Enzyme Gene Polymorphism and the Risk of Ischemic Heart DiseaseNew England Journal of Medicine, 1995
- Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.Circulation, 1994